Seeking Alpha

Chelsea Therapeutics tumbles as investors digest briefing docs

  • Briefing docs are out for next week's Northera (CHTP) Ad Com.
  • FDA staff list five arguments in favor of approval and seven against approval.
  • "The primary reason not to recommend approval is the lack of sufficient evidence of efficacy," the documents say.
  • Full documents
  • CHTP -21% premarket
Comments (1)
  • hneumann
    , contributor
    Comments (586) | Send Message
    Where on the FDA website todays Northera review can be found ?
    10 Jan, 02:11 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: